Literature DB >> 30717895

The Current Histologic Classification of Thyroid Cancer.

Sylvia L Asa1.   

Abstract

Thyroid cancers of follicular cell derivation provide excellent phenotype-genotype correlations. Current morphologic classifications are complex and require simplification. Benign adenomas have follicular or papillary architecture and bland cytology. Well-differentiated thyroid carcinomas exhibit follicular architecture, expansile growth, and variable cytologic atypia and invasiveness; low-risk tumors have excellent prognosis after surgical resection whereas widely-invasive and angioinvasive tumors warrant total thyroidectomy and radioablation. Papillary carcinoma is less differentiated; indolent microcarcinomas can be managed by active surveillance, whereas clinical lesions with local or distant spread require therapy. Progression gives rise to poorly differentiated and anaplastic carcinomas that are less common but far more aggressive.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classification; Cytology; Genotype-phenotype correlations; Histomorphology; Prognosis; Thyroid cancer

Mesh:

Year:  2019        PMID: 30717895     DOI: 10.1016/j.ecl.2018.10.001

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  26 in total

1.  Oncosuppressor-Mutated Cell-Based Diagnostic Platform for Liquid Biopsy Diagnoses Benign Head and Neck Masses and Predicts Malignancy in Thyroid Nodules: Results from a Consecutive Cohort of Patients.

Authors:  Mohamed Abdouh; Roger Tabah; Vincenzo Arena; Manuel Arena; Zu-Hua Gao; Aurelio Lorico; Goffredo Orazio Arena
Journal:  Eur Thyroid J       Date:  2021-06-07

Review 2.  Overview of the 2022 WHO Classification of Thyroid Neoplasms.

Authors:  Zubair W Baloch; Sylvia L Asa; Justine A Barletta; Ronald A Ghossein; C Christofer Juhlin; Chan Kwon Jung; Virginia A LiVolsi; Mauro G Papotti; Manuel Sobrinho-Simões; Giovanni Tallini; Ozgur Mete
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 3.943

3.  The relationship between autophagy-related genes and the staging and prognosis of thyroid cancer: a bioinformatics analysis.

Authors:  Qin Xu; Shan Gao; Jidong Miao
Journal:  Gland Surg       Date:  2021-08

4.  Role of papillary thyroid carcinoma patients with Hashimoto thyroiditis: evaluation of oxidative stress and inflammatory markers.

Authors:  Natália Medeiros Dias Lopes; Hannah Hamada Mendonça Lens; Walison Augusto da Silva Brito; Julya Karen Bianchi; Poliana Camila Marinello; Rubens Cecchini; André Armani; Alessandra Lourenço Cecchini
Journal:  Clin Transl Oncol       Date:  2022-07-28       Impact factor: 3.340

5.  Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies.

Authors:  Max Czajkowski; Daniel Kaemmerer; Jörg Sänger; Guido Sauter; Ralph M Wirtz; Stefan Schulz; Amelie Lupp
Journal:  BMC Cancer       Date:  2022-07-07       Impact factor: 4.638

Review 6.  Oncocytic Change in Thyroid Pathology.

Authors:  Sylvia L Asa; Ozgur Mete
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-03       Impact factor: 5.555

Review 7.  Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine.

Authors:  Antonio Ieni; Roberto Vita; Cristina Pizzimenti; Salvatore Benvenga; Giovanni Tuccari
Journal:  J Pers Med       Date:  2021-04-23

8.  Vitamin C sensitizes BRAFV600E thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK/ERK signal by PLX4032.

Authors:  Xi Su; Peng Li; Bin Han; Hao Jia; Qingzhuang Liang; Haichao Wang; Mengwei Gu; Jiaxuan Cai; Shaolei Li; Yaqi Zhou; Xin Yi; Wei Wei
Journal:  J Exp Clin Cancer Res       Date:  2021-01-19

Review 9.  BRAF Inhibitors in Thyroid Cancer: Clinical Impact, Mechanisms of Resistance and Future Perspectives.

Authors:  Fabiana Crispo; Tiziana Notarangelo; Michele Pietrafesa; Giacomo Lettini; Giovanni Storto; Alessandro Sgambato; Francesca Maddalena; Matteo Landriscina
Journal:  Cancers (Basel)       Date:  2019-09-18       Impact factor: 6.639

Review 10.  Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: implications in precision oncology-a narrative review.

Authors:  Xiaotian Yuan; Tiantian Liu; Dawei Xu
Journal:  Ann Transl Med       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.